Skip to search formSkip to main contentSkip to account menu

GAR 936

Known as: GAR-936 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tigecycline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The in Vitro Activity of Tigecycline and Antimicrobial Cross-Resistance Against Enterobacteriaceae Worldwide
2006
2006
In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
2004
2004
In Vitro Activities of Tigecycline (GAR-936) against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae
During recent years, a dramatic increase in bacterial resistance to antibiotics has been observed worldwide, both in community… 
2004
2004
Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections.
2004
2004
Quantitation of tigecycline, a novel glycylcycline [corrected] by liquid chromatography.
An ion-paired HPLC assay was developed to determine tigecycline (GAR-936) concentrations in Hank's balanced salts solution… 
Highly Cited
2003
Highly Cited
2003
In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides.
Sir, Increasing antimicrobial resistance among clinical isolates of staphylococci and enterococci has complicated the treatment… 
2003
2003
In Vitro Activities of Tigecycline (GAR-936) and 12 Other Antimicrobial Agents against 90 Eikenella corrodens Clinical Isolates
ABSTRACT The activity of tigecycline was compared with those of other antimicrobials against 90 isolates of Eikenella corrodens… 
2002
2002
Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus.
2001
2001
In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
GAR-936, a new, semisynthetic glycylcycline, has shown good antibacterial activity against a wide range of clinically important… 
1999
1999
New antimicrobial agents.
  • Y. Contrafouris
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 6427936
This section covered one of the most eagerly awaited topics during this year's ICAAC meeting, the discovery of new agents against… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)